Editas Medicine, Inc. (EDIT) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Key Points Company and Industry Information 1. Company: Editas Medicine, Inc. (NASDAQ:EDIT) 2. Industry: Biotechnology, Gene Editing 3. Event: 43rd Annual JPMorgan Healthcare Conference Call 4. Date: January 15, 2025 5. Time: 2:15 PM ET 6. Participants: - Gilmore O'Neill - President and Chief Executive Officer - Linda Burkly - Executive Vice President and Chief Scientific Officer - Erick Lucera - Executive Vice President and Chief Financial Officer - Brian Cheng - JPMorgan Senior Biotech Analyst - Miriam Yurco - Associate, JPMorgan [1] Core Views and Arguments 1. Progress and Vision: Editas Medicine aims to become a leader in vivo gene editing. 2. New Data Release: The company has released exciting new data this week. 3. Future Plans: Editas Medicine will discuss its plans for the current year and the next couple of years. [2] Forward-Looking Statements 1. Risk Disclosure: Gilmore O'Neill emphasizes the importance of reading the company's disclosure and filings for a full understanding of potential risks. [3] Additional Important Information 1. Historical Reference: O'Neill mentions an announcement made two years ago at the same conference. [3]